from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2959c/-

LFCtreatmentdescriptionclass of inhibitor

0.937

Amikacinug/mL Amikacintranslation

1.432

Cap5-10ug/mL Capreomycintranslation

1.325

Rox10-50 ug/mL Roxithromycintranslation

0.477

SM2-5 ug/mL Streptomycintranslation

2.604

Tet5-10 ug/mL Tetracyclinetranslation

0.028

Rif0.2-5ug/mL Rifampicintranscription

0.246

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.642

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.977

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.804

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.094

Clofazimine10-13 ug/mL Clofaziminerespiration

0.140

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.487

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.261

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-2.036

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.056

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.683

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.506

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.694

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.039

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.760

KCN5-20 ug/mL Potassium cyaniderespiration

-0.713

NaN30.2-2 mM Sodium aziderespiration

1.629

Nigericin50 uM Nigericinrespiration

-0.208

TRC10-150 ug/mL Triclosanrespiration

-0.710

TRZ10-25 ug/mL Thioridazinerespiration

0.246

Valinomycin0.5-10 uM Valinomycinrespiration

0.440

ZnSO42 mM ZnSO4respiration

0.161

menadione6-10 ug/mL Menadionerespiration

0.489

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.892

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.742

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.902

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.547

NRP_1Non-replicating persistence stage 1dosRassociated

0.528

Amp0.2mg/mL AmpicillincellWall

0.318

Cephalexin20-100 ug/mL CephalexincellWall

0.987

Cerulenin0.32-5 ug/mL CerulenincellWall

0.631

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.129

EMB10-20 ug/mL EthambutolcellWall

-0.461

Eta12-40 ug/mL EthionamidecellWall

0.072

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.189

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.536

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.384

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.102

BZA0.12 mg/mL BenzamidearomaticAmides

-0.420

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.700

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.043

H2O24 mM hydrogen peroxideDNAdamaging

1.066

Levo10 ug/mL LevofloxacinDNAdamaging

1.040

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.039

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.767

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.744

UVUV-irradiationDNAdamaging

-1.162

ARP41-4 ug/mL Antitubercular compound ARP4?

0.687

Antimycin12.5-50 ug/mL Antimycin A?

0.694

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.415

PA_110-50 ug/mL Antitubercular compound PA-1?

0.260

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.901

PA8240.2-2 ug/mL PA-824?

-1.032

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.020

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.132

Verapamil50 uM Verapamil?

0.291

mercaptoethanol2 mM 2-Mercaptoethanol?

0.904

methoxatin10-20 ug/mL Methoxatin?